FDA Approves Foot Ulcer Treatment Device


By: Diabetes Health Staff

The ArterioFlow 7500 is a pump that exerts pressure on an affected part of the body to force blood to flow more freely and widely. Increased blood flow is often the key to speeding up the healing of diabetic ulcers and preventing them from turning into infected wounds that can lead to gangrene and amputation.

Approximately 15 percent of people with diabetes develop foot ulcers, the result of impaired circulation or neuropathy brought on by inflammation from the disease. Of that total, the American Diabetes Association estimates that up to 24 percent will later undergo an amputation.

“Diabetic foot ulcers have proven to be the most common lower extremity injuries leading to amputation, and the compression therapy provided by the ArterioFlow increases blood flow to promote faster healing and prevent infection and amputation,” says Dr. John A. Bennett, CEO of Devon Medical Products. “While prevention of ulcers is ideal, immediate treatment of ulcers that do form is vital. Our goal with the ArterioFlow and all of our compression devices is to make therapy easy and convenient so that patients will comply more and in turn avoid terrible health consequences.”





Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.